[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
American Society for Experimental Neurotherapeutics Abstracts
February 2002

The Neurobiology of Mood Disorders

Arch Neurol. 2002;59(2):326. doi:

There have been major advances in our understanding of the neurobiology of depression. The roles of the monoamines, serotonin, and norepinephrine have remained a focus. However, given the complexity of these systems, more refined hypotheses have been developed. In addition, it has become more clear that other neurotransmitter systems, neuropeptides, and intracellular molecular mechanisms may be equally or even more important in the etiology and treatment of depression. This presentation will update the audience on recent findings pertaining to these areas. Possible new approaches to the treatment of depression based upon this work will be presented.